Detail of "4511-99-3"
- CAS Number:
- 4511-99-3
- Name:
1,2,4-Triazin-3-amine,5,6-diphenyl-
- Molecular Structure:

- Formula:
- C15H12 N4
- Molecular Weight:
- 248.28
- Synonyms:
- as-Triazine,3-amino-5,6-diphenyl- (6CI,7CI,8CI); 3-Amino-5,6-diphenyl-1,2,4-triazine; NSC58360
- Density:
- 1.229g/cm3
- Melting Point:
- 177 °C
- Boiling Point:
- 463.6°Cat760mmHg
- Flash Point:
- 265.2°C
- Hazard Symbols:

- Risk Codes:
- 36/37/38
- Safety:
Hazard Codes Xi Risk Statements 36/37/38 Safety Statements 26-36/37/39
Details
1,2,4-Triazin-3-amine,5,6-diphenyl-


| Hazard Codes | Xi |
| Risk Statements | 36/37/38 |
| Safety Statements | 26-36/37/39 |
Famous Chemical Enterprises
-
Livzon -
Total -
Shell -
Dupont -
Exxonmobil -
Akzonobel -
Basf -
Bayer -
BP
Please post your buying leads,so that our qualified suppliers
will soon contact you!
*Required Fields
Reference
- Some substituted imidazo[1,2-b][1,2,4]triazines and 8H-pyrimido[1,2-b][1,2,4]triazin-8-ones as potential antineoplastic agents
- Some substituted imidazo[1,2-b][1,2,4]triazines and 8H-pyrimido[1,2-b][1,2,4]triazin-8-ones as potential antineoplastic agents. Labouta, Ibrahim M.; Soliman, Farid S. G.; Kassem, Mohamed G. (Fac. Pharm., Univ. Alexandria, Alexandria, Egypt). Pharmazie, 41(11), 812-13 (English) 1986. CODEN: PHARAT. ISSN: 0031-7144. DOCUMENT TYPE: Journal CA Section: 28 (Heterocyclic Compounds (More Than One Hetero Atom)) Section cross-reference(s): 1 Imidazotriazines (I, R1 = Ph, C6H4OMe-4; R2 = Ph; R3 = NO2, Cl) and pyrimidotriazinones (II, R1 = Me, Ph, C6H4OMe-4; R2 = Me, Ph; R3 = Et, CH2Ph, H, BU) were prepd., and some were tested for antitumor activity. Aminoguanidine bicarbonate [2582-30-1] reacted with substituted dicarbonyl compds. to give 3-amino-5,6-disubstituted triazines which reacted with phenacyl bromides, followed by thermal cyclocondensation to give I; whereas the reaction of the aminotriazines with bis(2,4,6-trichlorophenyl) malonates gave II.In this experiment, several chemicals are used like 4511-99-3 None of the tested compds. had significant antitumor activity. .

